Title |
Adoptive T Cell Therapy Targeting CD1 and MR1
|
---|---|
Published in |
Frontiers in immunology, May 2015
|
DOI | 10.3389/fimmu.2015.00247 |
Pubmed ID | |
Authors |
Tingxi Guo, Kenji Chamoto, Naoto Hirano |
Abstract |
Adoptive T cell immunotherapy has demonstrated clinically relevant efficacy in treating malignant and infectious diseases. However, much of these therapies have been focused on enhancing, or generating de novo, effector functions of conventional T cells recognizing HLA molecules. Given the heterogeneity of HLA alleles, mismatched patients are ineligible for current HLA-restricted adoptive T cell therapies. CD1 and MR1 are class I-like monomorphic molecules and their restricted T cells possess unique T cell receptor specificity against entirely different classes of antigens. CD1 and MR1 molecules present lipid and vitamin B metabolite antigens, respectively, and offer a new front of targets for T cell therapies. This review will cover the recent progress in the basic research of CD1, MR1, and their restricted T cells that possess translational potential. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Belgium | 1 | 33% |
Russia | 1 | 33% |
Switzerland | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 5% |
United Kingdom | 1 | 2% |
Switzerland | 1 | 2% |
Unknown | 57 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 18 | 29% |
Researcher | 13 | 21% |
Student > Bachelor | 8 | 13% |
Professor | 4 | 6% |
Student > Doctoral Student | 3 | 5% |
Other | 9 | 15% |
Unknown | 7 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 19 | 31% |
Immunology and Microbiology | 16 | 26% |
Medicine and Dentistry | 9 | 15% |
Biochemistry, Genetics and Molecular Biology | 3 | 5% |
Chemistry | 2 | 3% |
Other | 6 | 10% |
Unknown | 7 | 11% |